Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform

Cnops, Lieselotte; Van den Eede, Peter; Pettitt, James; Heyndrickx, Leo; De Smet, Birgit; Coppens, Sandra; Andries, Ilse; Pattery, Theresa; Van Hove, Luc; Meersseman, Geert; Van Den Herrewegen, Sari; Vergauwe, Nicolas; Thijs, Rein; Jahrling, Peter B.; Nauwelaers, David; Ariën, Kevin K.
October 2016
Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS192
Academic Journal
Background. The 2013-2016 Ebola epidemic in West Africa resulted in accelerated development of rapid diagnostic tests for emergency outbreak preparedness. We describe the development and evaluation of the Idylla™ prototype Ebola virus test, a fully automated sample-to-result molecular diagnostic test for rapid detection of Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). Methods. The Idylla™ prototype Ebola virus test can simultaneously detect EBOV and SUDV in 200 μL of whole blood. The sample is directly added to a disposable cartridge containing all reagents for sample preparation, RNA extraction, and amplification by reverse-transcription polymerase chain reaction analysis. The performance was evaluated with a variety of sample types, including synthetic constructs and whole blood samples from healthy volunteers spiked with viral RNA, inactivated virus, and infectious virus. Results. The 95% limits of detection for EBOV and SUDV were 465 plaque-forming units (PFU)/mL (1010 copies/mL) and 324 PFU/mL (8204 copies/mL), respectively. In silico and in vitro analyses demonstrated 100% correct reactivity for EBOV and SUDV and no cross-reactivity with relevant pathogens. The diagnostic sensitivity was 97.4% (for EBOV) and 91.7% (for SUDV), the specificity was 100%, and the diagnostic accuracy was 95.9%. Conclusions. The Idylla™prototype Ebola virus test is a fast, safe, easy-to-use, and near-patient test that meets the performance criteria to detect EBOV in patients with suspected Ebola.


Related Articles

  • Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood. Benzine, Jason W.; Brown, Kerry M.; Agans, Krystle N.; Godiska, Ronald; Mire, Chad E.; Gowda, Krishne; Converse, Brandon; Geisbert, Thomas W.; Mead, David A.; Chander, Yogesh // Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS234 

    A molecular diagnostic method for robust detection of Ebola virus (EBOV) at the point of care (POC) directly from blood samples is described. This assay is based on reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) of the glycoprotein gene of EBOV. Complete reaction...

  • Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency. Strecker, Thomas; Palyi, Bernadett; Ellerbrok, Heinz; Jonckheere, Sylvie; de Clerck, Hilde; Bore, Joseph Akoi; Gabriel, Martin; Stoecker, Kilian; Eickmann, Markus; van Herp, Michel; Formenty, Pierre; Di Caro, Antonino; Becker, Stephan // Clinical Infectious Diseases;9/1/2015, Vol. 61 Issue 5, p699 

    Background. Reliable reverse transcription polymerase chain reaction (RT-PCR)-based diagnosis of Ebola virus infection currently requires a blood sample obtained by intravenous puncture. During the current Ebola outbreak in Guinea, we evaluated the usability of capillary blood samples collected...

  • Ebola Virus Disease Diagnostics, Sierra Leone: Analysis of Real-time Reverse Transcription-Polymerase Chain Reaction Values for Clinical Blood and Oral Swab Specimens. Erickson, Bobbie R.; Sealy, Tara K.; Flietstra, Tim; Morgan, Laura; Kargbo, Brima; Matt-Lebby, Victor E.; Gibbons, Aridth; Chakrabarti, Ayan K.; Graziano, James; Presser, Lance; Flint, Mike; Bird, Brian H.; Brown, Shelley; Klena, John D.; Blau, Dianna M.; Brault, Aaron C.; Belser, Jessica A.; Salzer, Johanna S.; Schuh, Amy J.; Lo, Michael // Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS258 

    During the Ebola virus outbreak of 2013-2016, the Viral Special Pathogens Branch field laboratory in Sierra Leone tested approximately 26 000 specimens between August 2014 and October 2015. Analysis of the B2M endogenous control Ct values showed its utility in monitoring specimen quality,...

  • Evaluation of RealStar Reverse Transcription-Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field. Rieger, Toni; Kerber, Romy; El Halas, Hussein; Pallasch, Elisa; Duraffour, Sophie; Günther, Stephan; Ölschläger, Stephan // Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS243 

    Background. Diagnosis of Ebola virus (EBOV) disease (EVD) requires laboratory testing. Methods. The RealStar Filovirus Screen reverse transcription-polymerase chain reaction (RT-PCR) kit and the derived RealStar Zaire Ebolavirus RT-PCR kit were validated using in vitro transcripts, supernatant...

  • FASTER AND CHEAPER. T. G. // ASEE Prism;Dec2014, Vol. 24 Issue 4, p15 

    The article reports that biomedical engineer James Collins at Harvard University's Wyss Institute for Biologically Inspired Engineering has developed a reverse transcription polymerase chain reaction (RT-PCR) to accurately diagnose the Ebola virus disease.

  • An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. Goba, Augustine; Khan, S. Humarr; Fonnie, Mbalu; Fullah, Mohamed; Moigboi, Alex; Kovoma, Alice; Sinnah, Vandi; Yoko, Nancy; Rogers, Hawa; Safai, Siddiki; Momoh, Mambu; Koroma, Veronica; Kamara, Fatima K.; Konowu, Edwin; Yillah, Mohamed; French, Issa; Mustapha, Ibraham; Kanneh, Franklyn; Foday, Momoh; McCarthy, Helena // Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS110 

    Background. Kenema Government Hospital (KGH) has developed an advanced clinical and laboratory research capacity to manage the threat of Lassa fever, a viral hemorrhagic fever (VHF). The 2013-2016 Ebola virus (EBOV) disease (EVD) outbreak is the first to have occurred in an area close to a...

  • Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015. Kerber, Romy; Krumkamp, Ralf; Diallo, Boubacar; Jaeger, Anna; Rudolf, Martin; Lanini, Simone; Bore, Joseph Akoi; Koundouno, Fara Raymond; Becker-Ziaja, Beate; Fleischmann, Erna; Stoecker, Kilian; Meschi, Silvia; Mély, Stéphane; Newman, Edmund N. C.; Carletti, Fabrizio; Portmann, Jasmine; Korva, Misa; Wolff, Svenja; Molkenthin, Peter; Kis, Zoltan // Journal of Infectious Diseases;2016 Supplement, Vol. 214, pS250 

    Background. A unit of the European Mobile Laboratory (EMLab) consortium was deployed to the Ebola virus disease (EVD) treatment unit in Guéckédou, Guinea, from March 2014 through March 2015. Methods. The unit diagnosed EVD and malaria, using the RealStar Filovirus Screen reverse...

  • Diagnosis of Febrile Illnesses Other Than Ebola Virus Disease at an Ebola Treatment Unit in Sierra Leone. O'Shea, Matthew K.; Clay, Kate A.; Craig, Darren G.; Matthews, Steven W.; Kao, Raymond L. C.; Fletcher, Thomas E.; Bailey, Mark S.; Hutley, Emma // Clinical Infectious Diseases;9/1/2015, Vol. 61 Issue 5, p795 

    Patients with febrile illnesses presenting to an Ebola treatment unit in Sierra Leone had a wide range of diagnoses other than Ebola virus disease. Rapid diagnostic tests were useful in confirming these diagnoses, reducing the length of patient stay with valuable consequences. These alternative...

  • Laboratory diagnosis of Ebola virus disease. Martin, Philippe; Laupland, Kevin B.; Frost, Eric H.; Valiquette, Louis // Intensive Care Medicine;May2015, Vol. 41 Issue 5, p895 

    The article discusses laboratory diagnostic tests to determine Ebola virus disease (EVD). Topics discussed include viral culture, reverse transcriptase polymerase chain reaction (RT-PCR), and enzyme-linked immunosorbent assay (ELISA) for detecting antigen and specific immunoglobulin M (IgM)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics